Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetone | HCID 180 | — |
| Reactant | Methyl iodide | HCID 6328 | — |
| Reactant | HCID 23035465 | HCID 23035465 | — |
| Product | HCID 14810902 | HCID 14810902 | — |
Reaction Steps
4-[2-(1-methylindol-3-yl)-1,3,4-oxadiazol-3-yl]pyridine (50 mg) was dissolved in dry acetone (10 ml), methyl iodide (127 mg) was then added, and the resulting solution heated at reflux for twenty four hours under a dry nitrogen atmosphere. The solution was allowed to cool to room temperature and the yellow solid isolated by filtration. Recrystallisation from acetone afforded the title compound (70 mg); m.p. 290° C. (dec); Found: C, 47.85; H, 3.56; N, 13.12; C17N16N4O15I requires C, 47.79; H, 3.77; N, 13.11%; δH (360 MHz, DMSO-d6) 3.98 (3H, s, N--CH3), 4.43 (3H, s, +N--CH3), 7.38 (2H, brm, H-5,6), 7.68 (1H, brm, H-4), 8.24 (1H, brm, H-7), 8.49 (1H, s, H-2), 8.70 (2H, d, J=8.4 Hz, CH=CH--N), 9.18 (2H, d, J=8.4 Hz, CH=CH--N); m/z (M+ free base 60%,) 276 (60), 158 (100), 127 (20), 103 (10), 77 (10).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04952587 |
|---|
| Source dataset | uspto-grants-1990_08 |
|---|
| ORD ID | ord-edf95eedb6ef409c970a14b2dafd57a8 |
|---|
| Source note | uspto-grants-1990_08 |
|---|